Khisimuzi Mdluli

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens”.

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens

Nature Communications(2021)10.1038/s41467-021-22833-6

N/A

2.0DataRank · unranked

98 citations

Sarah E. M. Born, Gregory T. Robertson, Matthew J. Reichlen, Christian Dide-Agossou, Victoria Ektnitphong +36 more

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479214

N/A

0DataRank · unranked

11 citations

Maria Santos Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni +25 more

A systematic efficacy analysis of tuberculosis treatment with BPaL‐containing regimens using a multiscale modeling approach

CPT Pharmacometrics & Systems Pharmacology(2024)10.1002/psp4.13117

N/A

0DataRank · unranked

11 citations

Laura E. Via, Danielle M. Weiner, Clifton E. Barry, Pariksheet Nanda, Gabrielle Michael +3 more